Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028465
Filing Date
2024-12-06
Accepted
2024-12-06 16:15:18
Documents
1
Period of Report
2024-03-05

Document Format Files

Seq Description Document Type Size
1 form4-12062024_041204.html 4  
1 form4-12062024_041204.xml 4 8202
  Complete submission text file 0001415889-24-028465.txt   10475
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Issuer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Reporting) CIK: 0001699737 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37524 | Film No.: 241532469

Mailing Address 251 CHURCHILL AVENUE PALO ALTO CA 94301
Business Address 251 CHURCHILL AVENUE PALO ALTO CA 94301 (650) 843-5000
Samsara BioCapital GP, LLC (Reporting) CIK: 0001888829 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37524 | Film No.: 241532470